Atlas Trials

Domperidone in Secondary Progressive Multiple Sclerosis (SPMS)

Clinical trial NCT02308137 · COMPLETED

Trial details

NCT number
NCT02308137
Sponsor
University of Calgary
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple Sclerosis, Secondary Progressive
Start date
2015-02-01
Primary completion
2020-01-03
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.